Preclinical Assessment of Leptin Transport into the Cerebrospinal Fluid in Diet-Induced Obese Minipigs.


Journal

Obesity (Silver Spring, Md.)
ISSN: 1930-739X
Titre abrégé: Obesity (Silver Spring)
Pays: United States
ID NLM: 101264860

Informations de publication

Date de publication:
06 2019
Historique:
received: 03 07 2018
accepted: 13 02 2019
pubmed: 23 4 2019
medline: 12 3 2020
entrez: 23 4 2019
Statut: ppublish

Résumé

A minipig model was employed to explore the changes in endogenous leptin transport into the central nervous system and in hypothalamic sensitivity to exogenous leptin when individuals are placed on high-fat diet (HFD) compared with standard diet. Serum and cerebrospinal fluid (CSF) leptin concentrations during 10 weeks of HFD versus standard diet and exogenous leptin-induced STAT3 phosphorylation in the hypothalamus of minipigs were assessed, and the hypothalamic leptin-sensitive cells were characterized by immunofluorescence. The efficiency of the passage of endogenous blood-borne leptin into the CSF (measured as the log [CSF:serum leptin ratio]) decreased over time in minipigs fed a HFD (β = -0.04 ± 0.005 per kilogram of weight gain in HFD; P < 0.0001), while it remained stable in minipigs fed a standard diet. However, the ability of peripherally administered leptin to activate its receptor in hypothalamic neurons was preserved in obese minipigs at 10 weeks of HFD. Together, these data are consistent with the existence of an early-onset tranport deficiency for endogenous circulating leptin into the brain in individuals developing obesity, preceding the acquisition of hypothalamic leptin resistance. Although additional studies are required to identify the underlying mechanisms, our study paves the way for the development of new preclinical pharmacological models targeting the restoration of the shuttling of peripheral leptin into the central nervous system to manage obesity.

Identifiants

pubmed: 31006983
doi: 10.1002/oby.22465
pmc: PMC6593767
doi:

Substances chimiques

Leptin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

950-956

Informations de copyright

© 2019 The Authors. Obesity published by Wiley Periodicals, Inc. on behalf of The Obesity Society (TOS).

Références

Science. 2016 Jul 8;353(6295):176-8
pubmed: 27387952
Endocrinology. 2004 Nov;145(11):4880-9
pubmed: 15271881
Cell Metab. 2013 Apr 2;17(4):607-17
pubmed: 23562080
Nat Neurosci. 2019 Jan;22(1):7-14
pubmed: 30531847
Diabetologia. 2016 May;59(5):920-7
pubmed: 26983921
Mol Metab. 2018 Jul;13:77-82
pubmed: 29748097
Diabetes Care. 2015 Aug;38(8):1567-82
pubmed: 26421334
Mol Metab. 2014 Oct 24;4(1):15-24
pubmed: 25685686
Cell Metab. 2014 Feb 4;19(2):293-301
pubmed: 24506870
Hepatology. 2009 Jul;50(1):56-67
pubmed: 19434740
J Clin Invest. 2000 Jun;105(12):1827-32
pubmed: 10862798
Lancet. 1996 Jul 20;348(9021):159-61
pubmed: 8684156
Cell Metab. 2015 Jun 2;21(6):877-82
pubmed: 25980347
Endocr Rev. 2018 Jun 1;39(3):333-368
pubmed: 29351662
J Comp Neurol. 2010 Feb 15;518(4):459-76
pubmed: 20017211
Br J Nutr. 2010 Dec;104(11):1719-28
pubmed: 20615269
Science. 2006 Feb 3;311(5761):629-32
pubmed: 16410488
Nat Neurosci. 2013 Jul;16(7):845-7
pubmed: 23708141
Nat Commun. 2015 Feb 27;6:6385
pubmed: 25721933
J Clin Invest. 1997 Feb 1;99(3):385-90
pubmed: 9022070
Mol Metab. 2018 Feb;8:13-22
pubmed: 29254602
Cell Metab. 2005 Jan;1(1):63-72
pubmed: 16054045
Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E10-5
pubmed: 12618361
Physiol Behav. 2010 Nov 2;101(4):462-8
pubmed: 20691715
Nat Med. 1996 May;2(5):589-93
pubmed: 8616722
J Clin Invest. 2005 Dec;115(12):3484-93
pubmed: 16284652
J Clin Invest. 2014 Oct;124(10):4473-88
pubmed: 25202980
Ann Intern Med. 2013 Dec 3;159(11):758-69
pubmed: 24297192
Nat Med. 1995 Dec;1(12):1311-4
pubmed: 7489415
Metabolism. 2015 Jan;64(1):1-4
pubmed: 25497341
J Vis Exp. 2011 Jun 26;(52):
pubmed: 21730947
J Chem Neuroanat. 2010 May;39(3):151-65
pubmed: 20043984
Nat Rev Neurosci. 2018 Feb;19(2):95-105
pubmed: 29321684

Auteurs

Alexandra Chmielewski (A)

Translational Research Laboratory for Diabetes, Inserm U1190, Lille, France.
European Genomic Institute for Diabetes (EGID), Lille, France.
Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Center, Inserm U1172, Lille, France.
School of Medicine, University of Lille, Lille, France.

Thomas Hubert (T)

Translational Research Laboratory for Diabetes, Inserm U1190, Lille, France.
European Genomic Institute for Diabetes (EGID), Lille, France.
School of Medicine, University of Lille, Lille, France.

Amandine Descamps (A)

Translational Research Laboratory for Diabetes, Inserm U1190, Lille, France.
European Genomic Institute for Diabetes (EGID), Lille, France.
School of Medicine, University of Lille, Lille, France.

Daniele Mazur (D)

Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Center, Inserm U1172, Lille, France.
School of Medicine, University of Lille, Lille, France.

Mehdi Daoudi (M)

Translational Research Laboratory for Diabetes, Inserm U1190, Lille, France.
European Genomic Institute for Diabetes (EGID), Lille, France.
School of Medicine, University of Lille, Lille, France.

Philippe Ciofi (P)

Inserm U862, Neurocentre Magendie, Bordeaux University, Bordeaux, France.

Christian Fontaine (C)

School of Medicine, University of Lille, Lille, France.
Anatomy Department, University of Lille, Lille, France.

Robert Caiazzo (R)

Translational Research Laboratory for Diabetes, Inserm U1190, Lille, France.
European Genomic Institute for Diabetes (EGID), Lille, France.
School of Medicine, University of Lille, Lille, France.

François Pattou (F)

Translational Research Laboratory for Diabetes, Inserm U1190, Lille, France.
European Genomic Institute for Diabetes (EGID), Lille, France.
School of Medicine, University of Lille, Lille, France.

Vincent Prevot (V)

European Genomic Institute for Diabetes (EGID), Lille, France.
Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Center, Inserm U1172, Lille, France.
School of Medicine, University of Lille, Lille, France.

Marie Pigeyre (M)

Translational Research Laboratory for Diabetes, Inserm U1190, Lille, France.
European Genomic Institute for Diabetes (EGID), Lille, France.
School of Medicine, University of Lille, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH